Similar articles

Abstract: Objective: To investigate whether vascular endothelial growth factor (VEGF) gene plasmid carried by polytetrafluoroethylene (PTFE) vascular graft materials could transfect endothelial cells (ECs) and promote their growth. Methods: PTFE vascular graft materials carried with pCDI-hVEGF₁₂₁, pCDI or pEGFP were incubated in Tris-buffer solution and the values of optical density of 260 nm at different time were plotted, then the DNA controlled release curve was made. ECs derived from human umbilical vein were seeded on the pCDI-hVEGF₁₂₁/pCDI/pEGFP-PTFE materials or tissue culture plates, ECs numbers were counted and VEGF protein concentrations at different time were measured by enzyme-linked immunoadsorbent assay method. Green fluorescent protein (GFP) expression in ECs on pEGFP-PTFE materials was examined with fluorescence microscopy. Results: The controlled release curve showed that the gene released from PTFE materials was rapid within 8 h, then slowed down and that the gene released continuously even after 72 h. At 24, 72 and 120 h, ECs number and proliferation rate of pCDI-hVEGF₁₂₁-PTFE materials were higher than those of pCDI or pEGFP-PTFE materials (P<0.05). VEGF protein concentration of pCDI-hVEGF₁₂₁-PTFE materials was higher than that of pCDI or pEGFP-PTFE materials at 6, 24, 72 and 120 h (P<0.01). GFP expression in ECs on the pEGFP-PTFE materials could be detected by fluorescence microscopy. Conclusion: PTFE graft can be used as a carrier of VEGF gene plasmid, VEGF gene carried by PTFE can transfect ECs and promote ECs growth.

[1] Anderson, J.S., Price, T.M., Hanson, S.R., Harker, L.A., 1987. In vitro endothelialization of small-caliber vascular grafts. Surgery, 101(5):577-586.

[2] Callow, A.D., 1982. Current status of vascular grafts. Surg. Clin. North Am., 62(3):501-513.

[3] Campbell, C.D., Brooks, D.H., Webster, M.W., Diamond, D.L., Peel, R.L., Bahnson, H.T., 1979. Expanded microporous polytetrafluoroethylene as a vascular substitute: a two year follow-up. Surgery, 85(2):177-183.

[4] Clowes, A.W., Kirkman, T.R., Reidy, M.A., 1986. Mechanisms of arterial graft healing. Rapid transmural capillary ingrowth provides a source of intimal endothelium and smooth muscle in porous PTFE prostheses. Am. J. Pathol., 123(2):220-230.

[5] Deutsch, M., Meinhart, J., Fischlein, T., Preiss, P., Zilla, P., 1999. Clinical autologous in vitro endothelialization of infrainguinal ePTFE grafts in 100 patients: a 9-year experience. Surgery, 126(5):847-855.

[6] Dorafshar, A.H., Angle, N., Bryer-Ash, M., Huang, D.S., Farooq, M.M., Gelabert, H.A., Freischlag, J.A., 2003. Vascular endothelial growth factor inhibits mitogen-induced vascular smooth muscle cell proliferation. J. Surg. Res., 114(2):179-186.

[7] Eickhoff, J.H., Broome, A., Ericsson, B.F., Buchardt Hansen, H.J., Kordtm, K.F., Mouritzen, C., Kvernebo, K., Norgren, L., Rostad, H., Trippestad, A., 1987. Four years’ results of a prospective, randomized clinical trial comparing polytetrafluoroethylene and modified human umbilical vein for below-knee femoropopliteal bypass. J. Vas. Surg., 6(5):506-511.

[8] Esquivel, C.O., Blaisdell, F.W., 1986. Why small caliber vascular grafts fail: a review of clinical and experimental experience and the significance of the interaction of blood at the interface. J. Surg. Res., 41(1):1-15.

[9] Ferrara, N., Henyel, W.J., 1989. Pituitarz follicular cells secrete a novel heparin-bindling growth factor specific for vascular endothelial cells. Biochem. Biophys. Res. Commun., 161(2):851-858.

[10] Grandas, O.H., Costanza, M.J., Donnell, R.L., Reddick, T.T., Carroll, R.C., Stevens, S.L., Freeman, M.B., Goldman, M.H., 2001. Effect of retroviral transduction of canine microvascular endothelial cells on beta(1) integrin subunit expression and cell retention to PTFE grafts. Cardiovasc. Surg., 9(6):595-599.

[11] Herring, M., Gardner, A., Glover, J., 1978. A single-staged technique for seeding vascular grafts with autogenous endothelium. Surgery, 84(4):498-504.

[12] Herring, M., Smith, J., Dalsing, M., Glover, J., Compton, R., Etchberger, K., Zollinger, T., 1994. Endothelial cell seeding of polytetrafluoroethylene femoral popliteal bypasses: the failure of low-density seeding to improve patency. J. Vasc. Surg., 20(4):650-655.

[13] Hood, J.D., Bednarski, M., Frausto, R., Guccione, S., Reisfeld, R.A., Xiang, R., Cheresh, D.A., 2002. Tumor regression by targeted gene delivery to the neovasculature. Science, 296(5577):2404-2407.

[14] Isner, J.M., Walsh, K., Symes, J., Pieczek, A., Takeshita, S., Lowry, J., Rosenfield, K., Weir, L., Brogi, E., Jurayj, D., 1996. Arterial gene transfer for therapeutic angiogenesis in patients with peripheral artery disease. Hum. Gene Ther., 7(8):959-988.

[15] Jaffe, E.A., Nachman, R.L., Becker, C.G., Minick, R., 1973. Culture of human endothelial cells derived from umbilical cord veins. Identification by morphologic and immunologic criteria. J. Clin. Invest., 52(11):2745-2756.

[16] Jensen, N., Lindblad, B., Bergqvist, D., 1994. Endothelial cell seeded dacron aortobifurcated grafts: platelet deposition and long-term follow-up. J. Cardiovasc. Surg., 35(5):425-429.

[17] Klugherz, B.D., Jones, P.L., Cui, X., Chen, W., Meneveau, N.F., DeFelice, S., Connolly, J., Wilensky, R.L., Levy, R.J., 2000. Gene delivery from a DNA controlled-release stent in porcine coronary arteries. Nat. Biotechnol., 18(11):1181-1184.

[18] Laitinen, M., Zachary, I., Breier, G., Pakkanen, T., Hakkinen, T., Luoma, J., Abedi, H., Risau, W., Soma, M., Laakso, M., Martin, J.F., Yla-Herttuala, S., 1997. VEGF gene transfer reduces intimal thickening via increased production of nitric oxide in carotid arteries. Hum. Gene Ther., 8(15):1734-1744.

[19] Leung, D.W., Cachianes, G., Kuang, W.J., Goeddel, D.V., Ferrara, N., 1989. Vascular endothelial growth factor is a secreted angiogenic mitogen. Science, 246(4935):1306-1309.

[20] Losordo, D.W., Pickering, G., Takeshita, S., Leclerc, G., Gal, D., Weir, L., Kearney, M., Jekanowski, J., Isner, J.M., 1994. Use of the rabbit ear artery to serially assess foreign protein secretion after site-specific arterial gene transfer in vivo. Circulation, 89(2):785-792.

[21] Losordo, D.W., Vale, P.R., Symes, J.F., Dunnington, C.H., Esakof, D.D., Maysky, M., Ashare, A.B., Lathi, K., Isner, J.M., 1998. Gene therapy for myocardial angiogenesis: initial clinical results with direct myocardial injection of phVEGF₁₆₅ as sole therapy for myocardial ischemia. Circulation, 98(25):2800-2804.

[22] Marin, V., Kaplanski, G., Sandra, G., Farnarier, C., Bongrand, P.J., 2001. Endothelial cell culture: protocol to obtain and cultivate human umbilical endothelial cells. J. Immunol. Methods, 254(1-2):183-190.

[23] Nabel, E.G., Yang, Z., Plautz, G., Forough, R., Zhan, X., Haudenschild, C.C., Maciag, T., Nabel, G.J., 1993. Recombinant fibroblast growth factor-1 promotes intimal hyperplasia and angiogenesis in arteries in vivo. Nature, 362(6423):844-846.

[24] Pearce, W.H., Rutherford, R.B., Whitehill, T.A., Rosales, C., Bell, K.P., Patt, A., Ramalanjaona, G., 1987. Successful endothelial seeding with omentally derived microvascular endothelial cells. J. Vasc. Surg., 5(1):203-206.

[25] Pels, K., Deiner, C., Coupland, S.E., Noutsias, M., Sutter, A.P., Schultheiss, H.P., Yla-Herttuala, S., Schwimmbeck, P.L., 2003. Effect of adventitial VEGF(165) gene transfer on vascular thickening after coronary artery balloon injury. Cardiovasc. Res., 60(3):664-672.

[26] Riessen, R., Rahimizadeh, H., Blessing, E., Takeshita, S., Barry, J.J., Isner, J.M., 1993. Arterial gene transfer using pure DNA applied directly to a hydrogel-coated angioplasty balloon. Hum. Gene Ther., 4(6):749-758.

[27] Shindo, S., Takagi, A., Whittemore, A.D., 1987. Improved patency of collagen-impregnated grafts after in vitro autogenous endothelial cell seeding. J. Vasc. Surg., 6(4):325-332.

[28] Shyu, K.G., Chang, H., Wang, B.W., Kuan, P., 2003. Intramuscular vascular endothelial growth factor gene therapy in patients with chronic critical leg ischemia. Am. J. Med., 114(2):85-92.

[29] Stansby, G., Berwanger, C., Shukla, N., Hamilton, G., 1994. Endothelial cell seeding of vascular grafts: status and prospects. Cardiovasc. Surg., 2(5):543-548.

[30] Takeshita, S., Tsurumi, Y., Couffinahl, T., Asahara, T., Bauters, C., Symes, J., Ferrara, N., Isner, J.M., 1996. Gene transfer of naked DNA encoding for three isoforms of vascular endothelial growth factor stimulates collateral development in vivo. Lab. Invest., 7(4):487-501.

[31] Tsurumi, Y., Murohara, T., Krasinski, K., 1997. Reciprocal relation between VEGF and NO in the regulation of endothelial integrity. Nat. Med., 3(8):879-886.

[32] van Belle, E., Tio, F.O., Chen, D., Maillard, L., Chen, D., Kearney, M., Isner, J.M., 1997. Passivation of metallic stents after arterial gene transfer of phVEGF165 inhibits thrombus formation and intimal thickening. J. Am. Coll. Cardiol., 29(6):1371-1379.

[33] Walter, D.H., Cejna, M., Diaz-Sandoval, L., Willis, S., Kirkwood, L., Stratford, P.W., Tietz, A.B., Kirchmair, R., Silver, M., Curry, C., et al., 2004. Local gene transfer of phVEGF-2 plasmid by gene-eluting stents: an alternative strategy for inhibition of restenosis. Circulation, 110(1):36-45.

[34] Yu, H., Dai, W., Yang, Z., Kirkman, P., Weaver, F.A., Eton, D., Rowe, V.L., 2003. Smooth muscle cells improve endothelial cell retention on polytetrafluoroethylene grafts in vivo. J. Vasc. Surg., 38(3):557-563.

[35] Yu, H., Dai, W., Yang, Z., Romaguera, R.L., Kirkman, P., Rowe, V.L., 2005. Neointimal hyperplasia on a cell-seeded polytetrafluoroethylene graft is promoted by transfer of tissue plasminogen activator gene and inhibited by transfer of nitric oxide synthase gene. J. Vasc. Surg., 41(1):122-129.